132 related articles for article (PubMed ID: 34184393)
1. Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients.
Hirama T; Singer LG; Brode SK; Marras TK; Husain S
Transpl Infect Dis; 2021 Aug; 23(4):e13679. PubMed ID: 34184393
[TBL] [Abstract][Full Text] [Related]
2. Non-tuberculous mycobacteria disease pre-lung transplantation: A systematic review of the treatment regimens and duration pre- and post-transplant.
van Gemert JP; Ravensbergen SJ; Verschuuren EAM; Kerstjens HAM; Willemse BWM; van Ingen J; Hoefsloot W; Gan T; Akkerman OW
Transplant Rev (Orlando); 2023 Dec; 37(4):100800. PubMed ID: 37832509
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.
Kim S; Woo A; Yong SH; Leem AY; Lee SH; Lee SH; Kim SY; Chung K; Kim EY; Jung JY; Kang YA; Park MS; Kim YS; Park Y
J Korean Med Sci; 2024 May; 39(20):e167. PubMed ID: 38804011
[TBL] [Abstract][Full Text] [Related]
4. Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes.
Park JH; Shin S; Kim TS; Park H
BMC Pulm Med; 2022 May; 22(1):195. PubMed ID: 35562714
[TBL] [Abstract][Full Text] [Related]
5. Clinical Impact of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease and Role of Computed Tomography in the Diagnosis.
Maruguchi N; Tanaka E; Okagaki N; Tanaka Y; Sakamoto H; Takeda A; Yamamoto R; Nakamura S; Matsumura K; Ueyama M; Ikegami N; Kaji Y; Hashimoto S; Hajiro T; Taguchi Y
Intern Med; 2023 Nov; 62(22):3291-3298. PubMed ID: 36927976
[TBL] [Abstract][Full Text] [Related]
6. Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host.
Varley CD; Streifel AC; Bair AM; Winthrop KL
Clin Chest Med; 2023 Dec; 44(4):829-838. PubMed ID: 37890919
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720.
Winthrop KL; Flume P; Hamed KA
Expert Rev Anti Infect Ther; 2023; 21(11):1177-1187. PubMed ID: 37862563
[TBL] [Abstract][Full Text] [Related]
8. Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.
Anidi IU; Olivier KN
Clin Chest Med; 2023 Dec; 44(4):839-845. PubMed ID: 37890920
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis.
Kwak N; Moon J; Kim JY; Park JW; Yim JJ
Adv Rheumatol; 2024 Mar; 64(1):20. PubMed ID: 38491558
[TBL] [Abstract][Full Text] [Related]
10. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
Sawka A; Burke A
Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
[TBL] [Abstract][Full Text] [Related]
11. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
Ying C; Zhang L; Jin X; Zhu D; Wu W
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study.
Martiniano SL; Caceres SM; Poch K; Rysavy NM; Lovell VK; Armantrout E; Jones M; Anthony M; Keck A; Nichols DP; Vandalfsen JM; Sagel SD; Wagner B; Xie J; Weaver K; Heltshe SL; Daley CL; Davidson RM; Nick JA;
J Cyst Fibros; 2024 Jan; 23(1):50-57. PubMed ID: 37666709
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic factors of non-tuberculous mycobacterial disease in patients with rheumatoid arthritis.
Kim H; Lee S; Kim JW; Jung JY; Suh CH; Kim HA
Korean J Intern Med; 2024 Jan; 39(1):172-183. PubMed ID: 38031367
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease.
Griffith DE; Aksamit TR
Clin Chest Med; 2023 Dec; 44(4):757-769. PubMed ID: 37890914
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.
Loebinger MR; Quint JK; van der Laan R; Obradovic M; Chawla R; Kishore A; van Ingen J
Chest; 2023 Nov; 164(5):1115-1124. PubMed ID: 37429481
[TBL] [Abstract][Full Text] [Related]
16. Building a model for the differential diagnosis of non-tuberculous mycobacterial lung disease and pulmonary tuberculosis: A case-control study based on immunological and radiological features.
Liu Q; Pan X; An H; Du J; Li X; Sun W; Gao Y; Li Y; Niu H; Gong W; Liang J
Int Immunopharmacol; 2023 Nov; 124(Pt B):111064. PubMed ID: 37857122
[TBL] [Abstract][Full Text] [Related]
17. Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease.
Choi JY; Shim B; Park Y; Kang YA
Korean J Intern Med; 2023 Nov; 38(6):879-892. PubMed ID: 37867139
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotypes of nontuberculous mycobacterial disease by cluster analysis based on pulmonary function.
Hamao N; Ito I; Oi I; Shirata M; Nishioka K; Hayashi Y; Imai S; Hirai T
Respir Med; 2024; 225():107600. PubMed ID: 38490432
[TBL] [Abstract][Full Text] [Related]
19. Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs.
Gu Y; Nie W; Huang H; Yu X
Front Cell Infect Microbiol; 2023; 13():1243457. PubMed ID: 37850054
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacterial infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation.
El Zein S; Mendoza MA; Wilson JW
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14127. PubMed ID: 37594211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
